Jacobs & Co. CA Increases Stake in Walgreens Boots Alliance Inc. (WBA)
Jacobs & Co. CA increased its stake in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 2.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 98,845 shares of the pharmacy operator’s stock after buying an additional 2,674 shares during the period. Walgreens Boots Alliance makes up 1.8% of Jacobs & Co. CA’s holdings, making the stock its 10th largest position. Jacobs & Co. CA’s holdings in Walgreens Boots Alliance were worth $7,968,000 as of its most recent filing with the SEC.
Several other hedge funds also recently added to or reduced their stakes in WBA. Jolley Asset Management LLC increased its stake in Walgreens Boots Alliance by 104.5% in the second quarter. Jolley Asset Management LLC now owns 1,370 shares of the pharmacy operator’s stock valued at $114,000 after buying an additional 700 shares during the period. Westbourne Investment Advisors Inc. bought a new stake in Walgreens Boots Alliance during the second quarter valued at about $121,000. Cribstone Capital Management LLC bought a new stake in Walgreens Boots Alliance during the second quarter valued at about $149,000. MU Investments Co. Ltd. bought a new stake in Walgreens Boots Alliance during the second quarter valued at about $150,000. Finally, Signaturefd LLC increased its stake in Walgreens Boots Alliance by 2.7% in the second quarter. Signaturefd LLC now owns 1,802 shares of the pharmacy operator’s stock valued at $150,000 after buying an additional 48 shares during the period. Institutional investors own 60.76% of the company’s stock.
Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded up 0.45% during midday trading on Friday, reaching $84.43. The company had a trading volume of 1,587,742 shares. Walgreens Boots Alliance Inc. has a 12 month low of $71.50 and a 12 month high of $87.05. The firm has a 50-day moving average of $81.28 and a 200-day moving average of $81.05. The stock has a market cap of $91.46 billion, a P/E ratio of 22.10 and a beta of 1.19.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 20th. The pharmacy operator reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.08. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. The company earned $28.60 billion during the quarter, compared to analysts’ expectations of $29.06 billion. During the same quarter in the previous year, the company posted $0.88 earnings per share. The business’s revenue was up .4% on a year-over-year basis. On average, equities analysts expect that Walgreens Boots Alliance Inc. will post $5.01 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 17th will be issued a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.78%. The ex-dividend date is Tuesday, November 15th. Walgreens Boots Alliance’s dividend payout ratio is presently 39.27%.
WBA has been the subject of several recent analyst reports. Jefferies Group upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and increased their target price for the company from $87.00 to $95.00 in a research note on Monday, October 17th. Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Thursday, October 6th. Deutsche Bank AG restated a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Wednesday, September 28th. Credit Suisse Group AG restated an “outperform” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Friday, October 21st. Finally, Wells Fargo & Co. initiated coverage on Walgreens Boots Alliance in a research note on Monday, October 31st. They set an “outperform” rating for the company. One research analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $90.30.
In related news, insider Stefano Pessina purchased 2,000,000 shares of the business’s stock in a transaction that occurred on Friday, November 4th. The stock was acquired at an average cost of $81.41 per share, for a total transaction of $162,820,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William C. Foote sold 2,067 shares of the business’s stock in a transaction that occurred on Wednesday, November 2nd. The shares were sold at an average price of $81.30, for a total value of $168,047.10. Following the completion of the sale, the director now owns 24,623 shares of the company’s stock, valued at $2,001,849.90. The disclosure for this sale can be found here. Insiders own 21.10% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.